Burosumab (Anti-FGF23)
Burosumab (Anti-FGF23) is a neutralizing antibody, targeting human fibroblast growth factor 23 (FGF23). It can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia. MW: 145.5 KD.
| Trivial name | KRN23 |
| Catalog Number | A2499 |
| CAS# | 1610833-03-8 |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/burosumab-anti-fgf23.html |